nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—stomach cancer	0.799	1	CbGaD
Tafluprost—Bimatoprost—AKR1C3—stomach cancer	0.00584	1	CrCbGaD
Tafluprost—Common cold—Fluorouracil—stomach cancer	0.00508	0.0802	CcSEcCtD
Tafluprost—Lacrimation increased—Floxuridine—stomach cancer	0.00441	0.0696	CcSEcCtD
Tafluprost—Photophobia—Floxuridine—stomach cancer	0.00381	0.0602	CcSEcCtD
Tafluprost—Punctate keratitis—Capecitabine—stomach cancer	0.00367	0.0579	CcSEcCtD
Tafluprost—PTGFR—smooth muscle tissue—stomach cancer	0.00339	0.165	CbGeAlD
Tafluprost—PTGFR—endocrine gland—stomach cancer	0.00221	0.108	CbGeAlD
Tafluprost—PTGFR—liver—stomach cancer	0.002	0.0971	CbGeAlD
Tafluprost—PTGS2—blood vessel—stomach cancer	0.00199	0.0968	CbGeAlD
Tafluprost—PTGS2—gall bladder—stomach cancer	0.00187	0.091	CbGeAlD
Tafluprost—Visual acuity reduced—Capecitabine—stomach cancer	0.00156	0.0246	CcSEcCtD
Tafluprost—Eye irritation—Fluorouracil—stomach cancer	0.00155	0.0245	CcSEcCtD
Tafluprost—PTGFR—lymph node—stomach cancer	0.00153	0.0745	CbGeAlD
Tafluprost—Lacrimation increased—Irinotecan—stomach cancer	0.0015	0.0237	CcSEcCtD
Tafluprost—Lacrimation increased—Fluorouracil—stomach cancer	0.00144	0.0227	CcSEcCtD
Tafluprost—Nervous system disorder—Floxuridine—stomach cancer	0.00142	0.0225	CcSEcCtD
Tafluprost—Vision blurred—Mitomycin—stomach cancer	0.00131	0.0207	CcSEcCtD
Tafluprost—Photophobia—Fluorouracil—stomach cancer	0.00124	0.0197	CcSEcCtD
Tafluprost—Cough—Mitomycin—stomach cancer	0.00122	0.0192	CcSEcCtD
Tafluprost—Eye irritation—Docetaxel—stomach cancer	0.00112	0.0177	CcSEcCtD
Tafluprost—Eye irritation—Capecitabine—stomach cancer	0.00108	0.0171	CcSEcCtD
Tafluprost—PTGS2—hematopoietic system—stomach cancer	0.00106	0.0515	CbGeAlD
Tafluprost—Lacrimation increased—Docetaxel—stomach cancer	0.00104	0.0164	CcSEcCtD
Tafluprost—Dyspnoea—Mitomycin—stomach cancer	0.00101	0.016	CcSEcCtD
Tafluprost—Lacrimation increased—Capecitabine—stomach cancer	0.001	0.0159	CcSEcCtD
Tafluprost—Cataract—Capecitabine—stomach cancer	0.000973	0.0154	CcSEcCtD
Tafluprost—PTGS2—epithelium—stomach cancer	0.000968	0.0471	CbGeAlD
Tafluprost—PTGS2—smooth muscle tissue—stomach cancer	0.000933	0.0454	CbGeAlD
Tafluprost—Headache—Floxuridine—stomach cancer	0.000907	0.0143	CcSEcCtD
Tafluprost—PTGS2—pancreas—stomach cancer	0.000862	0.042	CbGeAlD
Tafluprost—Nasopharyngitis—Fluorouracil—stomach cancer	0.00086	0.0136	CcSEcCtD
Tafluprost—Dry eye—Capecitabine—stomach cancer	0.000855	0.0135	CcSEcCtD
Tafluprost—PTGS2—lymphoid tissue—stomach cancer	0.000745	0.0363	CbGeAlD
Tafluprost—Eye pain—Capecitabine—stomach cancer	0.000745	0.0118	CcSEcCtD
Tafluprost—PTGS2—digestive system—stomach cancer	0.000736	0.0358	CbGeAlD
Tafluprost—Urinary tract infection—Fluorouracil—stomach cancer	0.00072	0.0114	CcSEcCtD
Tafluprost—Headache—Mitomycin—stomach cancer	0.000712	0.0113	CcSEcCtD
Tafluprost—Lacrimation increased—Epirubicin—stomach cancer	0.0007	0.0111	CcSEcCtD
Tafluprost—Rhinitis—Irinotecan—stomach cancer	0.000697	0.011	CcSEcCtD
Tafluprost—PTGS2—bone marrow—stomach cancer	0.000679	0.033	CbGeAlD
Tafluprost—Rhinitis—Fluorouracil—stomach cancer	0.000667	0.0105	CcSEcCtD
Tafluprost—Lacrimation increased—Doxorubicin—stomach cancer	0.000648	0.0102	CcSEcCtD
Tafluprost—Nasopharyngitis—Docetaxel—stomach cancer	0.000621	0.00981	CcSEcCtD
Tafluprost—PTGS2—endocrine gland—stomach cancer	0.000608	0.0296	CbGeAlD
Tafluprost—Nasopharyngitis—Capecitabine—stomach cancer	0.000601	0.0095	CcSEcCtD
Tafluprost—Dry eye—Epirubicin—stomach cancer	0.000596	0.00942	CcSEcCtD
Tafluprost—Asthma—Capecitabine—stomach cancer	0.000581	0.00918	CcSEcCtD
Tafluprost—Dry eye—Doxorubicin—stomach cancer	0.000551	0.00871	CcSEcCtD
Tafluprost—PTGS2—liver—stomach cancer	0.000549	0.0267	CbGeAlD
Tafluprost—Vision blurred—Fluorouracil—stomach cancer	0.000546	0.00863	CcSEcCtD
Tafluprost—Cough—Irinotecan—stomach cancer	0.000528	0.00834	CcSEcCtD
Tafluprost—Eye pain—Epirubicin—stomach cancer	0.000519	0.0082	CcSEcCtD
Tafluprost—Urinary tract infection—Capecitabine—stomach cancer	0.000503	0.00796	CcSEcCtD
Tafluprost—Nervous system disorder—Irinotecan—stomach cancer	0.000484	0.00765	CcSEcCtD
Tafluprost—Rhinitis—Docetaxel—stomach cancer	0.000481	0.00761	CcSEcCtD
Tafluprost—Eye pain—Doxorubicin—stomach cancer	0.00048	0.00759	CcSEcCtD
Tafluprost—Rhinitis—Capecitabine—stomach cancer	0.000466	0.00737	CcSEcCtD
Tafluprost—Nervous system disorder—Fluorouracil—stomach cancer	0.000464	0.00733	CcSEcCtD
Tafluprost—Eye disorder—Docetaxel—stomach cancer	0.000449	0.00709	CcSEcCtD
Tafluprost—Dyspnoea—Irinotecan—stomach cancer	0.00044	0.00696	CcSEcCtD
Tafluprost—Eye disorder—Capecitabine—stomach cancer	0.000435	0.00687	CcSEcCtD
Tafluprost—Asthma—Methotrexate—stomach cancer	0.000432	0.00684	CcSEcCtD
Tafluprost—Dyspnoea—Fluorouracil—stomach cancer	0.000421	0.00666	CcSEcCtD
Tafluprost—PTGS2—lymph node—stomach cancer	0.000421	0.0205	CbGeAlD
Tafluprost—Nasopharyngitis—Epirubicin—stomach cancer	0.000419	0.00662	CcSEcCtD
Tafluprost—Asthma—Epirubicin—stomach cancer	0.000405	0.0064	CcSEcCtD
Tafluprost—Nasopharyngitis—Doxorubicin—stomach cancer	0.000387	0.00612	CcSEcCtD
Tafluprost—Vision blurred—Capecitabine—stomach cancer	0.000381	0.00603	CcSEcCtD
Tafluprost—Asthma—Doxorubicin—stomach cancer	0.000374	0.00592	CcSEcCtD
Tafluprost—Cough—Docetaxel—stomach cancer	0.000365	0.00577	CcSEcCtD
Tafluprost—Cough—Capecitabine—stomach cancer	0.000353	0.00558	CcSEcCtD
Tafluprost—Urinary tract infection—Epirubicin—stomach cancer	0.000351	0.00554	CcSEcCtD
Tafluprost—Nervous system disorder—Docetaxel—stomach cancer	0.000335	0.00529	CcSEcCtD
Tafluprost—Pruritus—Fluorouracil—stomach cancer	0.000334	0.00529	CcSEcCtD
Tafluprost—Rhinitis—Epirubicin—stomach cancer	0.000325	0.00513	CcSEcCtD
Tafluprost—Urinary tract infection—Doxorubicin—stomach cancer	0.000325	0.00513	CcSEcCtD
Tafluprost—Nervous system disorder—Capecitabine—stomach cancer	0.000324	0.00512	CcSEcCtD
Tafluprost—Eye disorder—Methotrexate—stomach cancer	0.000323	0.00511	CcSEcCtD
Tafluprost—Headache—Irinotecan—stomach cancer	0.000309	0.00489	CcSEcCtD
Tafluprost—Dyspnoea—Docetaxel—stomach cancer	0.000304	0.00481	CcSEcCtD
Tafluprost—Eye disorder—Epirubicin—stomach cancer	0.000303	0.00479	CcSEcCtD
Tafluprost—Rhinitis—Doxorubicin—stomach cancer	0.0003	0.00475	CcSEcCtD
Tafluprost—Headache—Fluorouracil—stomach cancer	0.000296	0.00468	CcSEcCtD
Tafluprost—Dyspnoea—Capecitabine—stomach cancer	0.000295	0.00466	CcSEcCtD
Tafluprost—Vision blurred—Methotrexate—stomach cancer	0.000284	0.00449	CcSEcCtD
Tafluprost—Eye disorder—Doxorubicin—stomach cancer	0.00028	0.00443	CcSEcCtD
Tafluprost—Vision blurred—Epirubicin—stomach cancer	0.000266	0.0042	CcSEcCtD
Tafluprost—Cough—Methotrexate—stomach cancer	0.000263	0.00416	CcSEcCtD
Tafluprost—Cough—Epirubicin—stomach cancer	0.000246	0.00389	CcSEcCtD
Tafluprost—Vision blurred—Doxorubicin—stomach cancer	0.000246	0.00389	CcSEcCtD
Tafluprost—Pruritus—Docetaxel—stomach cancer	0.000241	0.00382	CcSEcCtD
Tafluprost—Nervous system disorder—Methotrexate—stomach cancer	0.000241	0.00381	CcSEcCtD
Tafluprost—Pruritus—Capecitabine—stomach cancer	0.000234	0.00369	CcSEcCtD
Tafluprost—Cough—Doxorubicin—stomach cancer	0.000228	0.0036	CcSEcCtD
Tafluprost—Nervous system disorder—Epirubicin—stomach cancer	0.000226	0.00357	CcSEcCtD
Tafluprost—Dyspnoea—Methotrexate—stomach cancer	0.000219	0.00347	CcSEcCtD
Tafluprost—Headache—Docetaxel—stomach cancer	0.000214	0.00338	CcSEcCtD
Tafluprost—Nervous system disorder—Doxorubicin—stomach cancer	0.000209	0.0033	CcSEcCtD
Tafluprost—Headache—Capecitabine—stomach cancer	0.000207	0.00327	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—AGTR2—stomach cancer	0.000206	0.00186	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	0.000206	0.00185	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	0.000205	0.00185	CbGpPWpGaD
Tafluprost—Dyspnoea—Epirubicin—stomach cancer	0.000205	0.00324	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—ADRB1—stomach cancer	0.000204	0.00184	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—F2R—stomach cancer	0.000204	0.00184	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000203	0.00183	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR1A—stomach cancer	0.000198	0.00179	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.000198	0.00178	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—ALB—stomach cancer	0.000197	0.00178	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	0.000196	0.00176	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	0.000194	0.00175	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKAB1—stomach cancer	0.000193	0.00174	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000193	0.00174	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—ANXA1—stomach cancer	0.000192	0.00173	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CDKN2A—stomach cancer	0.000192	0.00173	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CDK4—stomach cancer	0.000191	0.00172	CbGpPWpGaD
Tafluprost—Dyspnoea—Doxorubicin—stomach cancer	0.00019	0.003	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—KISS1—stomach cancer	0.000187	0.00168	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RNF43—stomach cancer	0.000187	0.00168	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000186	0.00168	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—ADRB1—stomach cancer	0.000186	0.00167	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000183	0.00165	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000183	0.00165	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—stomach cancer	0.000183	0.00165	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000178	0.0016	CbGpPWpGaD
Tafluprost—Pruritus—Methotrexate—stomach cancer	0.000174	0.00275	CcSEcCtD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000173	0.00156	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	0.000172	0.00156	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CDKN1B—stomach cancer	0.00017	0.00153	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	0.00017	0.00153	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ACAD8—stomach cancer	0.000167	0.00151	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	0.000167	0.0015	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FST—stomach cancer	0.000167	0.0015	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—ADRB2—stomach cancer	0.000166	0.00149	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	0.000165	0.00149	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000164	0.00148	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HBEGF—stomach cancer	0.000163	0.00147	CbGpPWpGaD
Tafluprost—Pruritus—Epirubicin—stomach cancer	0.000163	0.00257	CcSEcCtD
Tafluprost—PTGS2—C-MYB transcription factor network—CCND1—stomach cancer	0.000162	0.00146	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RGS2—stomach cancer	0.000161	0.00145	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GAST—stomach cancer	0.000161	0.00145	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL1B—stomach cancer	0.000161	0.00145	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000159	0.00144	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CDKN1A—stomach cancer	0.000157	0.00141	CbGpPWpGaD
Tafluprost—Headache—Methotrexate—stomach cancer	0.000154	0.00244	CcSEcCtD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000154	0.00139	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGG—stomach cancer	0.000152	0.00137	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—RHOA—stomach cancer	0.000151	0.00136	CbGpPWpGaD
Tafluprost—Pruritus—Doxorubicin—stomach cancer	0.000151	0.00238	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—ADRB2—stomach cancer	0.00015	0.00136	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GMPR2—stomach cancer	0.000149	0.00135	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PPP2R1A—stomach cancer	0.000147	0.00133	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000147	0.00133	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKAA1—stomach cancer	0.000147	0.00132	CbGpPWpGaD
Tafluprost—Headache—Epirubicin—stomach cancer	0.000144	0.00228	CcSEcCtD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000144	0.0013	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000142	0.00128	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RBP4—stomach cancer	0.000142	0.00128	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CXCL8—stomach cancer	0.000141	0.00128	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000141	0.00127	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SUCLG1—stomach cancer	0.000137	0.00123	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—IDH3B—stomach cancer	0.000137	0.00123	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PGLS—stomach cancer	0.000135	0.00122	CbGpPWpGaD
Tafluprost—Headache—Doxorubicin—stomach cancer	0.000133	0.00211	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL8—stomach cancer	0.000132	0.00119	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	0.00013	0.00117	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—MYC—stomach cancer	0.00013	0.00117	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CDKN1B—stomach cancer	0.000129	0.00117	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RBP1—stomach cancer	0.000129	0.00116	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL1B—stomach cancer	0.000127	0.00114	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NDUFS1—stomach cancer	0.000127	0.00114	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NDUFV1—stomach cancer	0.000127	0.00114	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000124	0.00112	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CCND1—stomach cancer	0.000123	0.00111	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	0.000122	0.0011	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HSPB1—stomach cancer	0.000122	0.0011	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AGTR2—stomach cancer	0.000122	0.0011	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BMP2—stomach cancer	0.00012	0.00109	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—F2R—stomach cancer	0.00012	0.00109	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—KRAS—stomach cancer	0.00012	0.00108	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MMP9—stomach cancer	0.00012	0.00108	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKR1C3—stomach cancer	0.000118	0.00107	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR1A—stomach cancer	0.000117	0.00106	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—stomach cancer	0.000116	0.00105	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FBP1—stomach cancer	0.000115	0.00104	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	0.000114	0.00103	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PRKCB—stomach cancer	0.000113	0.00102	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ANXA1—stomach cancer	0.000113	0.00102	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—BLVRB—stomach cancer	0.000113	0.00102	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PGLS—stomach cancer	0.000113	0.00102	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADRB1—stomach cancer	0.00011	0.000988	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPAP2A—stomach cancer	0.000108	0.000973	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RPS6—stomach cancer	0.000105	0.000944	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000104	0.000936	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PRKCB—stomach cancer	0.000103	0.000929	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6ST—stomach cancer	0.000103	0.000925	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PGAM1—stomach cancer	0.000102	0.000923	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	0.000102	0.000919	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	0.000102	0.000917	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MYC—stomach cancer	9.89e-05	0.000892	CbGpPWpGaD
Tafluprost—PTGS2—Disease—WIF1—stomach cancer	9.77e-05	0.000881	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	9.67e-05	0.000872	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	9.67e-05	0.000872	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HBEGF—stomach cancer	9.62e-05	0.000868	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CKB—stomach cancer	9.62e-05	0.000867	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—FBP1—stomach cancer	9.62e-05	0.000867	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NDUFA2—stomach cancer	9.62e-05	0.000867	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CA1—stomach cancer	9.62e-05	0.000867	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	9.49e-05	0.000856	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	9.4e-05	0.000848	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—stomach cancer	9.21e-05	0.000831	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RPL13—stomach cancer	9.18e-05	0.000828	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RPL18—stomach cancer	9.18e-05	0.000828	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6R—stomach cancer	9.16e-05	0.000826	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—RHOA—stomach cancer	9.11e-05	0.000821	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PLIN2—stomach cancer	9.04e-05	0.000816	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADRB2—stomach cancer	8.88e-05	0.000801	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CA2—stomach cancer	8.8e-05	0.000793	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	8.79e-05	0.000793	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RNF43—stomach cancer	8.71e-05	0.000785	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PPP2R1A—stomach cancer	8.7e-05	0.000785	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PGAM1—stomach cancer	8.57e-05	0.000773	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NT5E—stomach cancer	8.57e-05	0.000773	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RPS21—stomach cancer	8.56e-05	0.000772	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RPS15—stomach cancer	8.56e-05	0.000772	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	8.39e-05	0.000756	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	8.37e-05	0.000755	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—RHOA—stomach cancer	8.27e-05	0.000746	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALDH7A1—stomach cancer	8.18e-05	0.000738	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PLCE1—stomach cancer	8.18e-05	0.000738	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TP53—stomach cancer	8.12e-05	0.000732	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	8.11e-05	0.000732	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SMAD4—stomach cancer	8.08e-05	0.000729	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL8—stomach cancer	8e-05	0.000721	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	7.92e-05	0.000714	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—UMPS—stomach cancer	7.84e-05	0.000707	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FYN—stomach cancer	7.67e-05	0.000692	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—stomach cancer	7.43e-05	0.00067	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	7.31e-05	0.000659	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PDHA1—stomach cancer	7.29e-05	0.000657	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ECHS1—stomach cancer	7.29e-05	0.000657	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL8—stomach cancer	7.26e-05	0.000655	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGFR2—stomach cancer	7.2e-05	0.00065	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ALDOB—stomach cancer	7.1e-05	0.00064	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RPL15—stomach cancer	6.96e-05	0.000628	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	6.92e-05	0.000624	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—FADS1—stomach cancer	6.85e-05	0.000618	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—TYMP—stomach cancer	6.85e-05	0.000618	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NPM1—stomach cancer	6.83e-05	0.000616	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	6.73e-05	0.000607	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RBP4—stomach cancer	6.6e-05	0.000595	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IRS2—stomach cancer	6.6e-05	0.000595	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	6.58e-05	0.000593	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	6.58e-05	0.000593	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RPS26—stomach cancer	6.49e-05	0.000585	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PPIA—stomach cancer	6.44e-05	0.000581	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SREBF2—stomach cancer	6.42e-05	0.000579	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CAV1—stomach cancer	6.4e-05	0.000577	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APOA1—stomach cancer	6.38e-05	0.000575	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—RORA—stomach cancer	6.34e-05	0.000572	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	6.27e-05	0.000565	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	6.22e-05	0.00056	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKCB—stomach cancer	6.09e-05	0.000549	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6ST—stomach cancer	6.06e-05	0.000547	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALDOB—stomach cancer	5.94e-05	0.000536	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APC—stomach cancer	5.83e-05	0.000525	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	5.71e-05	0.000515	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.6e-05	0.000505	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.59e-05	0.000504	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MAPK3—stomach cancer	5.58e-05	0.000503	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALOX5—stomach cancer	5.53e-05	0.000498	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	5.52e-05	0.000498	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RPS19—stomach cancer	5.52e-05	0.000498	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKR1C3—stomach cancer	5.52e-05	0.000498	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—DPYD—stomach cancer	5.44e-05	0.00049	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6R—stomach cancer	5.41e-05	0.000488	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ENO1—stomach cancer	5.38e-05	0.000485	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MAPK1—stomach cancer	5.31e-05	0.000479	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—EGFR—stomach cancer	5.31e-05	0.000479	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CA—stomach cancer	5.07e-05	0.000457	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SERPINE1—stomach cancer	5.07e-05	0.000457	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—KRAS—stomach cancer	5.01e-05	0.000452	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.93e-05	0.000444	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RHOA—stomach cancer	4.89e-05	0.000441	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RPS6—stomach cancer	4.88e-05	0.00044	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOS3—stomach cancer	4.84e-05	0.000436	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTT1—stomach cancer	4.81e-05	0.000433	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD44—stomach cancer	4.77e-05	0.00043	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2A6—stomach cancer	4.75e-05	0.000428	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKR1C3—stomach cancer	4.62e-05	0.000417	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CA—stomach cancer	4.61e-05	0.000415	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ERBB2—stomach cancer	4.52e-05	0.000408	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ENO1—stomach cancer	4.5e-05	0.000406	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HBEGF—stomach cancer	4.48e-05	0.000404	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.43e-05	0.000399	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL8—stomach cancer	4.29e-05	0.000387	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HRAS—stomach cancer	4.26e-05	0.000384	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN1B—stomach cancer	4.19e-05	0.000378	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—stomach cancer	4.08e-05	0.000368	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PPP2R1A—stomach cancer	4.06e-05	0.000366	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCND1—stomach cancer	4e-05	0.00036	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CD44—stomach cancer	3.99e-05	0.00036	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JUN—stomach cancer	3.99e-05	0.00036	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—stomach cancer	3.88e-05	0.00035	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN1A—stomach cancer	3.87e-05	0.000349	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK8—stomach cancer	3.77e-05	0.00034	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SMAD4—stomach cancer	3.77e-05	0.00034	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FYN—stomach cancer	3.58e-05	0.000322	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFA—stomach cancer	3.48e-05	0.000314	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT3—stomach cancer	3.45e-05	0.000311	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ERCC2—stomach cancer	3.44e-05	0.00031	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPP2R1A—stomach cancer	3.4e-05	0.000306	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGFR2—stomach cancer	3.36e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTP1—stomach cancer	3.33e-05	0.0003	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK3—stomach cancer	3.3e-05	0.000297	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HMOX1—stomach cancer	3.29e-05	0.000296	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTHFR—stomach cancer	3.23e-05	0.000291	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MYC—stomach cancer	3.21e-05	0.000289	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK1—stomach cancer	3.14e-05	0.000283	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EGFR—stomach cancer	3.14e-05	0.000283	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—TYMS—stomach cancer	3.1e-05	0.000279	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IRS2—stomach cancer	3.07e-05	0.000277	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTM1—stomach cancer	3.06e-05	0.000276	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CAV1—stomach cancer	2.98e-05	0.000269	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOA1—stomach cancer	2.97e-05	0.000268	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KRAS—stomach cancer	2.96e-05	0.000267	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ERCC2—stomach cancer	2.88e-05	0.00026	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6ST—stomach cancer	2.83e-05	0.000255	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CA—stomach cancer	2.72e-05	0.000245	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APC—stomach cancer	2.71e-05	0.000245	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTHFR—stomach cancer	2.71e-05	0.000244	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TP53—stomach cancer	2.63e-05	0.000237	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6R—stomach cancer	2.52e-05	0.000227	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HRAS—stomach cancer	2.52e-05	0.000227	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CAV1—stomach cancer	2.5e-05	0.000225	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOA1—stomach cancer	2.49e-05	0.000225	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—stomach cancer	2.41e-05	0.000217	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.38e-05	0.000215	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SERPINE1—stomach cancer	2.36e-05	0.000213	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RHOA—stomach cancer	2.28e-05	0.000205	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS3—stomach cancer	2.25e-05	0.000203	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARG—stomach cancer	2.19e-05	0.000198	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ERBB2—stomach cancer	2.11e-05	0.00019	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—stomach cancer	1.97e-05	0.000178	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN1B—stomach cancer	1.95e-05	0.000176	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NOS3—stomach cancer	1.89e-05	0.00017	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN1A—stomach cancer	1.8e-05	0.000162	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT3—stomach cancer	1.61e-05	0.000145	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAPK3—stomach cancer	1.54e-05	0.000138	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MYC—stomach cancer	1.49e-05	0.000135	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAPK1—stomach cancer	1.46e-05	0.000132	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EGFR—stomach cancer	1.46e-05	0.000132	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KRAS—stomach cancer	1.38e-05	0.000124	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CA—stomach cancer	1.27e-05	0.000114	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HRAS—stomach cancer	1.17e-05	0.000106	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—stomach cancer	1.12e-05	0.000101	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CA—stomach cancer	1.06e-05	9.58e-05	CbGpPWpGaD
